MedTrace Logo

Study of Colchicine to Treat and Prevent Recurrent Pericarditis After Failure of Conventional Treatment.

NCT00235079 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2013-08-07

No results posted yet for this study

Summary

The purpose of the study is to determine whether colchicine is safe and effective in treatment and prevention of recurrent pericarditis after failure of conventional treatment.

Conditions

  • Pericarditis
  • Recurrence

Interventions

DRUG

Colchicine

Colchicine 0.5mg BID (\>70Kg) or 0.5 once daily for 6 months

DRUG

Placebo

Placebo comparator

Sponsors & Collaborators

  • Azienda Sanitaria Locale 3, Torino

    lead OTHER

Principal Investigators

  • Massimo Imazio, MD · Cardiology Department. Maria Vittoria Hospital. ASL 3 Torino (Coordinating Center)

  • Rita Trinchero, MD · Cardiology Department. Maria Vittoria Hospital. ASL 3 Torino (Coordinating Center).

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-11-30
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00235079 on ClinicalTrials.gov